electroCore, Inc. to Present at Little Grapevine’s G1 Microcap Virtual Conference
BASKING RIDGE, N.J., May 29, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that […]
RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program
SOUTH SAN FRANCISCO, Calif., May 29, 2020 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused […]
Candente Gold Advances new Growth Strategy
VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) — Candente Gold Corp. (TSXV:CDG) (“Candente Gold” and/or the “Company”) is pleased […]
Feronia Inc. Advises on Timing of Filing Interim Financial Statements and Management’s Discussion and Analysis
TORONTO, May 29, 2020 (GLOBE NEWSWIRE) — Feronia Inc. (“Feronia” or the “Company”) (TSX-V: FRN) today provides an update on […]
Verizon to redeem debt securities on June 29, 2020
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) (NYSE, NASDAQ: VZ) today announced that it will […]
NOVAGOLD Responds to Inaccurate Report from Short-Selling Firm
VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company”) (NYSE American, TSX: NG) […]
IGNITE Announces Acquisition of Ignite Distribution, Inc., Announces Name of New CFO, Provides Update on Annual Filings and Confirms Date of Filing of its Q1 Financial Statements and MD&A
VAUGHAN, Ontario, May 29, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a […]
Champignon Announces Voluntary Share Lock-Up; Retains Gold Standard Media, LLC for Financial Marketing Services
VANCOUVER, British Columbia, May 29, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) […]
Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma
– Vorasidenib Demonstrated Prolonged Disease Control and Encouraging Preliminary Activity with Median Progression-free Survival of 31.4 Months –– Vorasidenib Demonstrated […]
21Vianet Announces Appointment of Executive Chairman for its Retail IDC Business Group
BEIJING, May 29, 2020 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and […]
